Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
05/2007
05/03/2007WO2007049061A2 Conjugates of semaphorin peptides as imaging agents for cancer
05/03/2007WO2007021858A3 Methods of making radiolabeled tracers and precursors thereof
05/03/2007WO2002081649A3 ErbB INTERFACE PEPTIDOMIMETICS AND METHODS OF USE THEREOF
05/03/2007US20070098634 method of inhibiting the growth; inhibiting neoplastic cell growth; cancer
05/03/2007US20070098633 administering radiolabeled 18-(4-iodophenyl)-octadecylphosphocholine, using computed tomography/positron emission tomography or magnetic resonance imaging to produce visualization of three-dimensional morphology of selected region suspected, giving both anatomical and functional information
05/03/2007US20070098632 Analogs of terpene trilactones from ginkgo biloba and related compounds and uses thereof
05/03/2007US20070098631 Diagnostic compounds comprising a scaffold coupled to a signal entity for medical imaging diagnostic
05/03/2007DE19940220B4 Medizinisches Präparat zur Behandlung von Arthrose, Arthritis und anderen rheumatischen Gelenkerkrankungen A medical preparation for the treatment of osteoarthritis, arthritis and other rheumatic joint diseases
05/02/2007EP1778299A2 Methods for preparing multivalent constructs for therapeutic and diagnostic applications
05/02/2007EP1778298A2 Lipoprotein nanoplatforms
05/02/2007EP0906426B1 Antibodies to the ed-b domain of fibronectin, their construction and uses
05/02/2007CN1313436C Tumor imaging compounds
05/02/2007CN1313161C Radiative immune guiding operating medicine of colorectal disease and preparation method thereof
05/01/2007CA2192813C Methods of inducing gene expression by ionizing radiation
05/01/2007CA2166676C Diagnostic agent for hypoxia or mitochondrial dysfunction comprising radioactive copper complex of dithiosemicarbazone derivative or diamine diol schiff base derivative
04/2007
04/26/2007WO2007047204A1 Isotopically-labeled benzofuran compounds as imagingagents foramyloidogenic proteins
04/26/2007WO2007000671A3 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells
04/26/2007WO2006083983A3 Bridgehead radiolabelled compounds and methods of using the same
04/26/2007US20070092447 Contrast agent for combined modality imaging and methods and systems thereof
04/26/2007US20070092444 Inhibition of inward sodium currents in cancer
04/26/2007US20070092443 Antibodies That Recognize Hyperproliferative Cells and Methods of Making and Using Same
04/26/2007US20070092442 F-18-fluorinated phosphonium cation imaging agents and methods of synthesis
04/26/2007US20070092441 Fluoridation method
04/26/2007US20070092440 Bone localising radiopharmaceutical and tubulin-interacting compound combinatorial
04/25/2007EP1776144A2 Heat shock protein as a targeting agent for endothelium-specific in vivo transduction
04/25/2007CN1953772A Contrast medium for receptor of angiotensin ii
04/25/2007CN1953771A Perturbed membrane-binding compounds and methods of using the same
04/24/2007US7208525 Diagnostic agents for pancreatic exocrine function
04/24/2007US7208471 Glycopeptide phosphonate derivatives
04/24/2007US7208466 Treating pain or inflammation; inhibiting C-fibre neuron activity; hemagglutinins conjugated with protein
04/24/2007US7208173 Mixed structures resulting from the incorporation of a biological macromolecule, especially of DNA, in a liquid crystal phase of amphiphiles, and vesicles obtained using these structures
04/24/2007US7208140 Trimeric macrocyclic substituted benzene derivatives
04/24/2007US7208139 Conducting nuclear spin tomography on a patient who has been administered a cascade polymer complex having complex-forming ligands for imaging of inflammation and/or tumors in the brain
04/24/2007CA2073855C Glycoalkaloids for controlling cellular autophagy
04/19/2007WO2007042506A1 Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
04/19/2007WO2007013894A3 Phospholipid ether analogs for detecting and treating cancer
04/19/2007WO2006036288A3 Method for monitoring early treatment response
04/19/2007WO2004088279A3 Allosteric probes and methods
04/19/2007US20070088085 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
04/19/2007US20070086975 Polymeric micellar complexes and drug delivery vehicles thereof
04/19/2007US20070086945 Preparations for diagnosis of pancreatic exocrine function
04/19/2007US20070086944 Covalently binding an antioxidant such as ascorbic acid, p-aminobenzoic acid, cysteine, monothioglycerol, or gentisic acid with ligand: Oxa-PnAO, N,N-dimethyl Gly-Ser-Cys-Gly, N,N-dimethyl-Gly-t-butylGly-Cys-Gly, or 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid; optional targeting molecule
04/19/2007US20070086943 antibodies that immunospecifically bind to tyrosine kinase receptors (EphA2) and competes for binding to EphA2 with the EA5 antibody, used for cancer therapy
04/19/2007US20070086942 Methods and compositions for generating bioactive assemblies of increased complexity and uses
04/19/2007CA2625207A1 Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
04/19/2007CA2624802A1 Latent procytotoxins and uses thereof
04/19/2007CA2624794A1 Automated radiolabelling method
04/18/2007EP1773408A2 Virtual colonoscopy with radiolabeled phospholipid ether analogs
04/18/2007EP1401479B1 Detection and therapy of vulnerable plaque with photodynamic compounds
04/18/2007EP1379266B1 Modified annexin proteins and prevention and treatment of thrombosis
04/18/2007EP1334194B1 Imaging, diagnosis and treatment of disease
04/18/2007EP1276718B1 Small technetium-99m and rhenium labeled agents and methods for imaging tumors
04/18/2007EP1135160B1 Boron neutron capture therapy using pre-targeting methods
04/18/2007CN1950329A Radioactive tyrosine derivative, method for producing same, labeling agent for positron imaging and medical agent for assessing grade of malignancy of tumor respectively composed of radioactive tyrosi
04/18/2007CN1950111A Activatable particles, preparations and uses.
04/18/2007CN1948311A 2-iodine substituted phenyl-6-trifluoro methyl imidazole [1,2-a]-pyridine-3-acetamide compounds and its preparation method
04/18/2007CN1310680C Device for synthesis of radiopharmaceutical products
04/18/2007CN1310617C Ingestible pill
04/17/2007US7205006 Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
04/17/2007US7204972 Annexin derivatives with endogenous chelation sites
04/17/2007US7204797 Delivery methods, systems and components for use with hazardous pharmaceutical substances
04/12/2007WO2007041611A2 Microtubule synthesis as a biomarker
04/12/2007WO2007041452A2 Methods for preparation of live body tissue for examination
04/12/2007WO2007041025A2 Radiolabeled glycine transporter inhibitors
04/12/2007WO2007039437A1 Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents
04/12/2007WO2007005491B1 Hydrazide conjugates as imaging agents
04/12/2007WO2006032704A3 Diagnostic compounds for targeting a chemokine receptor
04/12/2007WO2005060683A3 Small peptides for the treatment of alzheimer’s disease and other beta-amyloid protein fibrillogenesis disorders
04/12/2007US20070082849 Angiogenic peptides and uses thereof
04/12/2007US20070081946 Assembly of gas-filled microvesicle with active component for contrast imaging
04/12/2007US20070081943 Alpha 4 beta 2 delta gaba-a receptors as a strategy for pms and alcoholism
04/12/2007US20070081942 Gene differentially expressed in breast and bladder cancer, and encoded polypeptides
04/12/2007US20070081941 F-18 Labeled Amino Acid Analogs
04/12/2007US20070081940 Radioactive source materials formable into various shapes
04/12/2007CA2854550A1 Av.beta.6 peptide ligands and their uses
04/12/2007CA2621960A1 Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents
04/11/2007EP1772462A2 Steroid sulfamates, method for the production and use thereof
04/11/2007EP1772452A2 Matrix metalloproteinase inhibitors and uses thereof
04/11/2007EP1772157A1 Modular assembly and synthesis method for the production of radiopharmaceuticals and nuclides
04/11/2007EP1771209A2 Stabilized and lyophilized radiopharmaceutical agents
04/11/2007EP1771208A2 Use of thioflavin radiolabeled derivatives in amyloid imaging for assessing anti-amyloid therapies
04/11/2007EP1592476B1 Methods for the purification of stable radioiodine conjugates
04/11/2007EP1307237B1 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof
04/11/2007EP1175227B1 Monoclonal antibody directed against cells of human renal cell carcinoma
04/11/2007EP0980441B1 Methods for measuring cellular proliferation and destruction rates in vitro and in vivo
04/11/2007EP0741748B1 Monoclonal antibodies specific to vegf receptors and uses thereof
04/11/2007CN1946742A Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
04/11/2007CN1946432A Particulate materials and compositions for radio therapy
04/11/2007CN1946431A Compositions and methods for topical application and transdermal delivery of botulinum toxins
04/10/2007US7202330 RGD (Arg-Gly-Asp) coupled to (neuro)peptides
04/10/2007US7201890 Parenterally injecting patient with labeled divalent single chain antibody fragment or subfragment; conducting procedure within 48 hours of the injection; scanning the accessed interior locating sites of accretion of labeled antibody
04/10/2007CA2236001C Biologically active eph family ligands
04/10/2007CA2190108C Somatostatin binding peptide-metal chelate conjugates
04/05/2007WO2007038641A2 Methods and therapies for treating inflammatory conditions with exposed collagen
04/05/2007WO2007038074A1 Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands
04/05/2007WO2007008232A9 Locoregional internal radionuclide ablation of abnormal tissues.
04/05/2007WO2007000145A3 Analysis method for determining a functional parameter of an organ using preferably an aqueous 13c methacetin solution
04/05/2007WO2006096499A3 Mr coronary angiography with a fluorinated nanoparticle contrast agent at 1.5 t
04/05/2007WO2006090232A3 Radiolabeled gallium complexes, methods for synthesis and use for pet imaging of egfr epxression in malignant tumors
04/05/2007WO2006084030B1 Small-molecule hsp90 inhibitors